Wiseguyreports.Com Adds “Allergy Immunotherapy -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database
The report titled “Global Allergy Immunotherapy Market: Trends & Opportunities (2015-2019)” provides an in-depth analysis of the global allergy immunotherapy market with detailed analysis of market sizing and growth, market share and economic impact of the industry. Global allergy immunotherapy market penetration rate is also provided in the report. The report also provides market size of allergic rhino conjunctivitis (AR) and HDM allergy disease. The report provides detailed market share analysis of the global allergy immunotherapy market by types, regions and players. The market share of allergy immunotherapy market in the respiratory market and prescription allergy market is also explained in detailed.
The report provides detail regional analysis of the allergy immunotherapy market in the United States and Europe. In regional analysis market by value, key players are provided with market for pipeline products.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global allergy immunotherapy industry has also been forecasted for the period 2014-2019, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition is global allergy immunotherapy market is stiff and dominated by the big players like ALK-Abello. Further, key players of the allergy immunotherapy industry like ALK-Abello, Stallergenes; and Allergy Therapeutics are also profiled with their financial information and respective business strategies.
- United States
- Allergy Therapeutics
Allergen immunotherapy, also known as “allergy shots”, is a form of long-term treatment that decreases symptoms for many people with allergic rhinitis, allergic asthma, conjunctivitis (eye allergy) or stinging insect allergy. Allergy shots decrease sensitivity to allergens that’s why it is known as “desensitization or hypo-sensitization” and often lead to lasting relief of allergy symptoms even after treatment is stopped. This makes it a cost-effective, beneficial treatment approach for many people. Allergen immunotherapy is a preventive treatment for allergic reactions to substances such as grass pollens, house dust mites and bee venom. Whole allergen immunotherapy is the only treatment that targets the actual cause of the allergy and attempts to re-educate the immune system to tolerate the allergen.
In the 2013 ‘World Allergy Organization White Book’, the WHO estimated that there were 400 million people in the world suffering from allergic rhinitis and 300 million from asthma, which shows the scale of the problem. The most common allergens found in the US and Europe.
Patients presenting with allergies are questioned and the tested in an attempt to ascertain exactly what they are allergic to. Once this has been identified, a treatment regime can be put in place. However, the approaches in the US and Europe are quite different, largely because of differences in product availability. The type of product used falls into three categories: SCIT, SLITD and SLITT.
Table of Contents
1. Executive Summary
2.3 Allergic Response
Type I reactions – IgE-Mediated Allergies
2.4 Types of Allergy
2.9 Allergen Immunotherapy
2.9.1 Allergy Vaccines
2.9.3 Role of Adjuvants
3-O-desacyl-4’-monophosphoryl lipid A (MPL)
3. Global Allergy Therapeutics Market: An Analysis
4. Allergy Immunotherapy Market: Regional Analysis
5. Market Dynamics
6. Competitive Landscape
7. Company Profiles
7.1 Allergy Therapeutics
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)